Registered entities
SAPIENCE THERAPEUTICS, INC.
Reg. No. 5854319United States
Sapience Therapeutics, Inc.
Reg. No. 4838960United States
Innovation
10 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 427 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 4 |
Social engagement
Social engagement: 4.3K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include NexPoint.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Private equity | 1 | 13% |
| Accelerator & incubator | 1 | 13% |
| Other / undisclosed | 4 | 50% |
Recent activity
22 May 2026
Event
ASCO26
13 Apr 2026
Event
25th Annual Needham & Company Virtual Healthcare Conference
18 Mar 2026
Event
AACR2026